Literature DB >> 13940853

Control of anticoagulant therapy. The use of new tests.

P A OWREN.   

Abstract

Keywords:  ANTICOAGULANTS; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; HEMOSTASIS

Mesh:

Substances:

Year:  1963        PMID: 13940853     DOI: 10.1001/archinte.1963.03620260108019

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


× No keyword cloud information.
  7 in total

1.  Decrease of normotest/thrombotest discrepancy in non-contacted coumarin plasma after glass or ellagic acid activation.

Authors:  A Girolami; G Patrassi; A Burul
Journal:  Blut       Date:  1976-07

2.  Double blind study of the effect of glafenine (Glifanan) on oral anticoagulant therapy with phenprocoumon (Marcumar).

Authors:  J K Boeijinga; W J van der Vijgh
Journal:  Eur J Clin Pharmacol       Date:  1977-12-02       Impact factor: 2.953

Review 3.  [Drugs interacting with coumarine oral anticoagulants (author's transl)].

Authors:  R Gugler; H J Dengler
Journal:  Klin Wochenschr       Date:  1973-11-15

Review 4.  Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations.

Authors:  G Palareti; C Legnani
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

5.  Relationship between liver function and splenic blood flow (quantitative measurement of splenic blood flow with H2(15)O and a dynamic state method: 2).

Authors:  A Oguro; H Taniguchi; H Koyama; H Tanaka; K Miyata; K Takeuchi; T Inaba; H Nakahashi; T Takahashi
Journal:  Ann Nucl Med       Date:  1993-11       Impact factor: 2.668

6.  AN INVESTIGATION OF THE HEMORRHAGIC DIATHESIS IN PATIENTS RECEIVING COUMARIN AND INDANEDIONE ANTICOAGULANTS.

Authors:  C W BAUGH
Journal:  Can Med Assoc J       Date:  1965-01-16       Impact factor: 8.262

7.  Risk factors for embolisation in patients with left ventricular thrombi and acute myocardial infarction.

Authors:  K A Johannessen; J E Nordrehaug; G von der Lippe; S E Vollset
Journal:  Br Heart J       Date:  1988-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.